Drug class
Overactive Bladder Agents
Overactive bladder agents are a therapeutic class of pharmaceuticals formulated to manage urinary storage dysfunction characterized by urgency, urinary frequency, and urge incontinence. Read more about Overactive Bladder Agents
151 drugs in this class 73 manufacturers
Drugs in Overactive Bladder Agents
GEMTESA (vibegron)
TROSPIUM CHLORIDE
TOLTERODINE TARTRATE
OXYBUTYNIN CHLORIDE
FESOTERODINE FUMARATE ER (fesoterodine fumarate)
OXYBUTYNIN CHLORIDE ER (oxybutynin chloride)
TOLTERODINE TARTRATE ER (tolterodine tartrate)
SOLIFENACIN SUCCINATE
Overactive bladder agents are a therapeutic class of pharmaceuticals formulated to manage urinary storage dysfunction characterized by urgency, urinary frequency, and urge incontinence.
The class primarily includes antimuscarinic drugs, which inhibit acetylcholine-mediated detrusor muscle contractions, and beta-3 adrenergic receptor agonists, which promote detrusor relaxation to enhance bladder storage capacity.
Clinically, these medications are indicated for idiopathic overactive bladder syndrome and detrusor overactivity associated with neurological conditions such as spinal cord injury or multiple sclerosis.
-
urologytimes.com
Overactive bladder agents are a therapeutic class of pharmaceuticals formulated to manage urinary storage dysfunction characterized by urgency, urinary frequency, and urge incontinence
-
nih.gov
Overactive bladder agents are a therapeutic class of pharmaceuticals formulated to manage urinary storage dysfunction characterized by urgency, urinary frequency, and urge incontinence The class primarily includes antimuscarinic drugs, which inhibit acetylcholine-mediated detrusor muscle contractions, and beta-3 adrenergic receptor agonists, which promote detrusor relaxation to enhance bladder storage capacity
-
nih.gov
Overactive bladder agents are a therapeutic class of pharmaceuticals formulated to manage urinary storage dysfunction characterized by urgency, urinary frequency, and urge incontinence Clinically, these medications are indicated for idiopathic overactive bladder syndrome and detrusor overactivity associated with neurological conditions such as spinal cord injury or multiple sclerosis
-
mayoclinic.org
The class primarily includes antimuscarinic drugs, which inhibit acetylcholine-mediated detrusor muscle contractions, and beta-3 adrenergic receptor agonists, which promote detrusor relaxation to enhance bladder storage capacity
-
youtube.com
The class primarily includes antimuscarinic drugs, which inhibit acetylcholine-mediated detrusor muscle contractions, and beta-3 adrenergic receptor agonists, which promote detrusor relaxation to enhance bladder storage capacity
-
medicalnewstoday.com
The class primarily includes antimuscarinic drugs, which inhibit acetylcholine-mediated detrusor muscle contractions, and beta-3 adrenergic receptor agonists, which promote detrusor relaxation to enhance bladder storage capacity
-
fda.gov
Clinically, these medications are indicated for idiopathic overactive bladder syndrome and detrusor overactivity associated with neurological conditions such as spinal cord injury or multiple sclerosis
-
fda.gov
Clinically, these medications are indicated for idiopathic overactive bladder syndrome and detrusor overactivity associated with neurological conditions such as spinal cord injury or multiple sclerosis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.